Mammalian TAF(II)30 is required for cell cycle progression and specific cellular differentiation programmes

EMBO Journal

Volumn 18, Issue 17, 1999, Pages 4823-4834

  Metzger, Daniel ^a   Scheer, Elisabeth ^a   Soldatov, Aleksey ^b   Tora, Làszlò ^a  

^a CNRS   (France)

^b INSTITUTE OF GENE BIOLOGY   (Russian Federation)

Author keywords

Apoptosis; Conditional gene knock out; Cre recombinase; Proliferation; TFIID

Indexed keywords

BINDING PROTEIN; CYCLIC AMP; CYCLIN E; RECOMBINASE; RETINOBLASTOMA PROTEIN; RETINOIC ACID; TATA BINDING PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYONAL CARCINOMA; ENDODERM; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, EMBRYONAL; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; INTEGRASES; MICE; MICE, KNOCKOUT; MODELS, GENETIC; MUTAGENESIS, INSERTIONAL; STEM CELLS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TIME FACTORS; TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 0033198877     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.17.4823     Document Type: Article

References (48)

1. 2/M but not for general transcription activation. Genes Dev., 10, 2368-2380.
2. Bartek, J., Bartkova, J. and Lukas, J. (1997) The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res., 237, 1-6.
3. II-containing complexes. Exp. Cell. Res., 246, 11-19.
4. II-containing complex subunits suggests a role in nucleosome acetylation and signal transduction. J. Biol. Chem., 274, 18285-18289.
5. Chiba, H., Clifford, J., Metzger, D. and Chambon, P. (1997a) Specific and redundant functions of retinoid X receptor/retinoic acid receptor heterodimers in differentiation, proliferation and apoptosis of F9 embryonal carcinoma cells. J. Cell Biol., 139, 735-747.
6. Chiba, H., Clifford, J., Metzger, D. and Chambon, P. (1997b) Distinct retinoid X receptor/retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Mol. Cell. Biol., 17, 3013-3020.
7. Clifford, J., Chiba, H., Sobieszczuk, D., Metzger, D. and Chambon, P. (1996) RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J., 15, 4142-4155.
8. Freeman, R.S., Estus, S. and Johnson, E.M.,Jr (1994) Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron, 12, 343-355.
9. Gong, J., Traganos, F. and Darzynkiewicz, Z. (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem., 218, 314-319.
10. Goodrich, J.A., Cutler, G. and Tjian, R. (1996) Contacts in context: promoter specificity and macromolecular interactions in transcription. Cell, 84, 825-830.
11. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
12. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W. and Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766-1769.
13. IIs are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation. Cell, 94, 45-53.
14. 1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev., 8, 1759-1771.
15. II30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell, 79, 107-117.
16. Lecoeur, H. and Gougeon, M.L. (1996) Comparative analysis of flow cytometric methods for apoptosis quantitation in murine thymocytes and human peripheral lymphocytes from controls and HIV-infected persons. Evidence for interference by granulocytes and erythrocytes. J. Immunol. Methods, 198, 87-99.
17. Lundberg, A.S. and Weinberg, R.A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol., 18, 753-761.
18. II28 promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J., 15, 3093-3104.
19. McBurney, M.W., Sutherland, L.C., Adra, C.N., Leclair, B., Rudnicki, M.A. and Jardine, K. (1991) The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res., 19, 5755-5761.
20. II28: three subunits of the human transcription factor TFIID. EMBO J., 14, 1520-1531.
21. II135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3 and thyroid hormone receptors in mammalian cells. Genes Dev., 11, 1381-1395.
22. Metzger, D., Clifford, J., Chiba, H. and Chambon, P. (1995) Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl Acad. Sci. USA, 92, 6991-6995.
23. Moqtaderi, Z., Bai, Y., Poon, D., Weil, P.A. and Struhl, K. (1996a) TBP-associated factors are not generally required for transcriptional activation in yeast. Nature, 383, 188-191.
24. Moqtaderi, Z., Yale, J.D., Struhl, K. and Buratowski, S. (1996b) Yeast homologues of higher eukaryotic TFIID subunits. Proc. Natl Acad. Sci. USA, 93, 14654-14658.
25. Niforas, P., Chu, M.D. and Bird, P. (1996) A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells. Gene, 176, 139-147.
26. Ogryzko, V.V., Kotani, T., Zhang, X., Schlitz, R.L., Howard, T., Yang, X.J., Howard, B.H., Qin, J. and Nakatani, Y. (1998) Histone-like TAFs within the PCAF histone acetylase complex. Cell, 94, 35-44.
27. Philippe, J., Louagie, H., Thierens, H., Vral, A., Cornelissen, M. and De Ridder, L. (1997) Quantification of apoptosis in lymphocyte subsets and effect of apoptosis on apparent expression of membrane antigens. Cytometry, 29, 242-249.
28. Pugh, B.F. and Tjian, R. (1991) Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev., 5, 1935-1945.
29. 1-S transition. Cancer Surv., 29, 7-23.
30. Sauer, B. and Henderson, N. (1990) Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol., 2, 441-449.
31. II30). Genomics, 29, 269-272.
32. 1 phase, encodes a 210-kilodalton nuclear DNA-binding protein. Mol. Cell. Biol., 11, 3317-3325.
33. 1 phase progression: cycling on cue. Cell, 79, 551-555.
34. Strickland, S. and Mahdavi, V. (1978) The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell, 15, 393-403.
35. Strickland, S., Smith, K.K. and Marotti, K.R. (1980) Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell, 21, 347-355.
36. Sumi-Ichinose, C., Ichinose, H., Metzger, D. and Chambon, P. (1997) SNF2β-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells. Mol. Cell. Biol., 17, 5976-5986.
37. 1 at the nonpermissive temperature. Mol. Cell. Biol., 17, 3284-3294.
38. Tansey, W.P. and Herr, W. (1997) TAFs: guilt by association? Cell, 88, 729-732.
39. te Riele, H., Maandag, E.R., Clarke, A., Hooper, M. and Berns, A. (1990) Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature, 348, 649-651.
40. IIs. Nature, 383, 185-188.
41. 1/S cyclin genes and regulated by the cellular growth state. Cell, 90, 607-614.
42. II250. Science, 263, 811-814.
43. II250-dependent transcription of cyclin A is directed by ATF activator proteins. Genes Dev., 11, 2658-2669.
44. White, J., Brou, C., Wu, J., Lutz, Y., Moncollin, V. and Chambon, P. (1992) The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexes. EMBO J., 11, 2229-2240.
45. II-containing complex without TBP in transcription by RNA polymerase II. Nature, 393, 187-191.
46. II105 mediates activation of anti-apoptotic genes by NF-κB. EMBO J., 17, 5161-5169.
47. II mutations disrupt dorsal activation in the Drosophila embryo. Proc. Natl Acad. Sci. USA, 95, 13483-13488.
48. Zhou, Q., Lieberman, P.M., Boyer, T.G. and Berk, A.J. (1992) Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. Genes Dev., 6, 1964-1974.